Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. MRK
MRK logo

MRK

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MRK News

ARS Pharmaceuticals Announces CEO Succession

3h agoNASDAQ.COM

Novo Nordisk Faces Challenges but Optimistic Outlook Ahead

14h agoFool

U.S. Healthcare Spending Reaches $5.7 Trillion Amid Growth Trends

16h agoFool

Eli Lilly and Intuitive Surgical's Growth Potential

16h agoNASDAQ.COM

iShares Core High Dividend ETF Outperforms S&P 500

1d agoFool

iShares Core High Dividend ETF Surges Over 15% Year-to-Date

1d agoNASDAQ.COM

Market Health Signals: Strong Performance in Healthcare and Agriculture Stocks

1d agoCNBC

SCHD Delivers 227% Return Over 10 Years with Strong Cash Flow Stability

2d agoYahoo Finance

Schwab U.S. Dividend ETF Shows Strong Performance

5d agoNASDAQ.COM

The Potential and Returns of Dividend Investing

5d agoFool

Moderna's Expanding Pipeline Sparks Investor Interest

6d agoCNBC

Merck Halts Alzheimer’s Drug Trial MK-1167 Due to Poor Performance

6d agostocktwits

Merck Halts Development of Alzheimer's Drug MK-1167

6d agoseekingalpha

DFUS Stock Price Analysis and ETF Dynamics

6d agoNASDAQ.COM

Merck Schedules Q2 2026 Earnings Call for Investors

6d agoNewsfilter

Merck Stock Pullback but Outlook Remains Positive

Jun 30 2026seekingalpha